The company intends to use the funds for ongoing technology and software development, additional patent filings, and sales and marketing.
Led by Sam Zamarripa, president, Intent Solutions provides TAD™ is a smart, mobile, medication dispenser that enables patients to take the right dose at the right time.
The medical device, which can be programmed to a specific regimen and schedule, incorporates biometric access and is fully tamper resistant. It also records adherence data, which is sent to a cloud database for analysis, reducing errors and simplifying data reconciliation for clinical trials.
TAD was conceived by Dr. Van Crisco, chairman, and Marty McClean, a director of the company.
FinSMEs
14/11/2016